LISATA THERAPEUTICS, INC. Equity Method Investment, Ownership Percentage
LISATA THERAPEUTICS, INC. (LSTA) had Equity Method Investment, Ownership Percentage of 19.90% as of 2016-03-11, per its 10-K filed 2019-03-14.
Discontinued › Notes › Investments
us-gaap:EquityMethodInvestmentOwnershipPercentage · last filed 2019-03-14
- 2016-03-11: Equity Method Investment, Ownership Percentage 19.90%.
- 2012-06-30: Equity Method Investment, Ownership Percentage 51.00%.
- 2009-10-31: Equity Method Investment, Ownership Percentage 51.00%.
| Period end | Equity Method Investment, Ownership Percentage |
|---|---|
| 2016-03-11 | 19.90% 10-K · filed 2019-03-14 |
| 2012-06-30 | 51.00% 10-K · filed 2013-03-11 |
| 2009-10-31 | 51.00% 10-K · filed 2013-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |